NBY
AMEX · Pharmaceuticals
Novabay Pharmaceuticals Inc
$1.04
+0.01 (+0.97%)
Open$1.05
Previous Close$1.03
Day High$1.10
Day Low$1.02
52W High$99.75
52W Low—
Volume—
Avg Volume98.2K
Market Cap51.92M
P/E Ratio—
EPS$-4.09
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 143.78M | 136.78M | 19.57M |
| Net Income | -106,178,835 | -90,906,536 | 4.44M |
| Profit Margin | -73.9% | -70.2% | 22.7% |
| EBITDA | -105,135,468 | -95,013,978 | 7.02M |
| Free Cash Flow | — | — | 4.00M |
| Rev Growth | +5.1% | +5.1% | -0.9% |
| Debt/Equity | 0.34 | 0.34 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |